Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1865729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ciprofloxacin, a fluorinated quinolone with high efficacy against Pseudomonas aeruginosa, was used in the treatment of 10 consecutive patients with malignant external otitis. All patients had skull base osteomyelitis documented by nuclear and computed tomography (CT) scans. Dosages of 1.5 g of ciprofloxacin daily were used for a mean average of 10 weeks. All patients were considered cured with a minimum follow-up of 18 months after completion of therapy. A new classification of malignant external otitis (MEO) is presented.
Medical subject headings
- Ciprofloxacin
- Osteomyelitis
- Otitis Externa
- Pseudomonas Infections